CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Filters
1 research outputs found
Red blood cell (RBC) transfusion rates among US chronic dialysis patients during changes to Medicare end-stage renal disease (ESRD) reimbursement systems and erythropoiesis stimulating agent (ESA) labels
Author
AF Eder
AK Singh
+31 more
Amgen Inc
Amgen Inc
BJ Manns
BM Gilliss
Carly J Paoli
Department of Health and Human Services
DS Fuller
DT Gilbertson
GJ Despotis
GT Obrador
Helen V Varker
HN Ibrahim
JA Sargent
JW Adamson
JW Eschbach
Katherine A Cappell
KDOQI
M Gitlin
MA Pfeffer
Matthew Gitlin
ME Charlson
Medicare Program
RA Deyo
RY Dodd
Sanatan Shreay
SM Brunelli
TB Drueke
The DOPPS Practice Monitor
US Renal Data System
US Renal Data System
Zhun Cao
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Full text link
